RxDoctor Payments Data

Erika Cottrell, MD

Physical Medicine & Rehabilitation · Mooresville, INNPI 1891986337

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Nevro Corp. accounts for 67.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $505 and has fallen 91.4% since, to $44 in 2025.

$850in general payments, 2019–2025

Across 16 payments — averaging $53.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$574
  • Boston Scientific$70
  • SPR Therapeutics, Inc$47
  • Abbott$40
  • Averitas Pharma Inc.$34
  • Vertex$25
  • plus $59 from 4 others

What the payments were for

  • Food & beverage$850100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$850 in reported general payments places this provider in the 60th percentile of 140 physical medicine & rehabilitation providers in Indiana.

See all physical medicine & rehabilitation providers in Indiana

Medicare billing

Part B allowed, 2024
$81,630
Medicare patients
214
Services billed
1,563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin312$5,086
Pregabalin61$2,172
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen170$1,824
Tramadol Hcl60$664
Tizanidine Hcl58$579
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$554
Cyclobenzaprine Hcl59$482
Celecoxib11$453
Methocarbamol39$403
Oxycodone Hcl24$401
Ropinirole Hcl27$288
Pramipexole DihydrochloridePramipexole Di-Hcl13$270
Diclofenac Sodium11$254
Baclofen15$237
Methylprednisolone44$226

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Mooresville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →